JPS6232724B2 - - Google Patents

Info

Publication number
JPS6232724B2
JPS6232724B2 JP56050150A JP5015081A JPS6232724B2 JP S6232724 B2 JPS6232724 B2 JP S6232724B2 JP 56050150 A JP56050150 A JP 56050150A JP 5015081 A JP5015081 A JP 5015081A JP S6232724 B2 JPS6232724 B2 JP S6232724B2
Authority
JP
Japan
Prior art keywords
asthma
effect
trapidil
tracheal
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP56050150A
Other languages
English (en)
Japanese (ja)
Other versions
JPS57165318A (en
Inventor
Haruo Oonishi
Chihiro Ito
Suguru Mochida
Norio Taira
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mochida Pharmaceutical Co Ltd
Original Assignee
Mochida Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharmaceutical Co Ltd filed Critical Mochida Pharmaceutical Co Ltd
Priority to JP56050150A priority Critical patent/JPS57165318A/ja
Priority to CA000399904A priority patent/CA1184494A/en
Priority to PCT/JP1982/000101 priority patent/WO1982003328A1/ja
Priority to DE19823239714 priority patent/DE3239714C2/de
Priority to EP82901007A priority patent/EP0075029B1/en
Priority to GB08229372A priority patent/GB2119245B/en
Publication of JPS57165318A publication Critical patent/JPS57165318A/ja
Publication of JPS6232724B2 publication Critical patent/JPS6232724B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP56050150A 1981-04-03 1981-04-03 Remedy for asthma Granted JPS57165318A (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP56050150A JPS57165318A (en) 1981-04-03 1981-04-03 Remedy for asthma
CA000399904A CA1184494A (en) 1981-04-03 1982-03-31 Pharmaceutical composition for treatment of chronic occlusive pulmonary diseases
PCT/JP1982/000101 WO1982003328A1 (en) 1981-04-03 1982-04-03 Agent for treating chronic obliterative lung disease
DE19823239714 DE3239714C2 (de) 1981-04-03 1982-04-03 Verwendung von 5-Methyl-7-dietylamino-s-triazolo-(1,5-a)-pyrimidin zusammen mit einem }blichen pharmazeutisch annehmbaren Tr{ger zur Behandlung von chronischen okklusiven Lungenerkrankungen
EP82901007A EP0075029B1 (en) 1981-04-03 1982-04-03 Agent for treating chronic obliterative lung disease
GB08229372A GB2119245B (en) 1981-04-03 1982-04-03 Agent for treating chronic obliterative lung disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56050150A JPS57165318A (en) 1981-04-03 1981-04-03 Remedy for asthma

Publications (2)

Publication Number Publication Date
JPS57165318A JPS57165318A (en) 1982-10-12
JPS6232724B2 true JPS6232724B2 (2) 1987-07-16

Family

ID=12851151

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56050150A Granted JPS57165318A (en) 1981-04-03 1981-04-03 Remedy for asthma

Country Status (6)

Country Link
EP (1) EP0075029B1 (2)
JP (1) JPS57165318A (2)
CA (1) CA1184494A (2)
DE (1) DE3239714C2 (2)
GB (1) GB2119245B (2)
WO (1) WO1982003328A1 (2)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7527872B2 (en) 2005-10-25 2009-05-05 Goodrich Corporation Treated aluminum article and method for making same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4954396A (2) * 1973-06-07 1974-05-27
US4223031A (en) * 1978-05-05 1980-09-16 Mead Johnson & Company Azolopyrimidinones
FR2448542A1 (fr) * 1979-02-06 1980-09-05 Landerlan Sa Lab Derives de triazolapyrimidine utiles comme medicaments

Also Published As

Publication number Publication date
EP0075029A1 (en) 1983-03-30
EP0075029B1 (en) 1986-10-29
GB2119245B (en) 1986-01-08
DE3239714C2 (de) 1986-06-05
GB2119245A (en) 1983-11-16
WO1982003328A1 (en) 1982-10-14
JPS57165318A (en) 1982-10-12
EP0075029A4 (en) 1984-03-06
CA1184494A (en) 1985-03-26
DE3239714T1 (de) 1983-03-24

Similar Documents

Publication Publication Date Title
Brown et al. The use of sodium bicarbonate in the treatment of tricyclic antidepressant-induced arrhythmias
Gross et al. Anticholinergic, antimuscarinic bronchodilators
Wood et al. Intravenous isoproterenol in the management of respiratory failure in childhood status asthmaticus
Leahy et al. Comparison of nebulized salbutamol with nebulized ipratropium bromide in acute asthma
Gross et al. The longterm treatment of an asthmatic patient using phentolamine
Ikeda et al. Comparative dose-response study of three anticholinergic agents and fenoterol using a metered dose inhaler in patients with chronic obstructive pulmonary disease.
JP3172188B2 (ja) 肺および気管支疾患におけるウロジラチン（ｕｒｏｄｉｌａｔｉｎ）の使用
Manfredi et al. Severe carbon dioxide intoxication: treatment with organic buffer (trihydroxymethylaminomethane)
Geumei et al. Evaluation of a new oral β2-adrenoceptor stimulant bronchodilator, terbutaline
Patel et al. The dose‐duration effect of sodium cromoglycate in exercise‐induced asthma
JPS6232724B2 (2)
Massey et al. Ipratropium bromide
Laursen et al. Effects of enprofylline and theophylline on exercise‐induced asthma
Tanigaki et al. Rapid response to inhaled frusemide in severe acute asthma with hypercapnia
Funahashi et al. A study of a new bronchodilator: Carbuterol
Svedmyr Effects of Oral Theophylline Combined with Oral and Inhaled β2‐Adrenostimulants in Asthmatics
Stirt et al. Lack of arrhythmogenicity of isoflurane following administration of aminophylline in dogs
Brogden et al. Terbutaline: a preliminary report of its pharmacological properties and therapeutic efficacy in asthma
JPS62294614A (ja) ベンゾ〔ｃ〕〔１，６〕ナフチリジン誘導体からなる新規医薬組成物
JPH0753358A (ja) 吸入剤
JPH0245603B2 (2)
JPH0517358A (ja) 睡眠誘起性無呼吸症治療剤
DeNicola et al. Drug therapy approaches in the treatment of acute severe asthma in hospitalised children
JPS59216821A (ja) 気道閉塞性障害治療・予防剤
TW201121540A (en) Treatment of acute exacerbation of asthma and reduction of likelihood of hospitalization of patients suffering therefrom